Eris Lifesciences gets ₹17-crore GST show cause notice over Novartis trademark deal

The expected financial implication, as mentioned in the notice, is IGST of ₹16,84,67,040 along with applicable interest at 18% per annum from November 27, 2019. The penalty has not been specified in the notice. Shares of Eris Lifesciences Ltd ended at ₹1,772, up by ₹21.30 or 1.22%, on the BSE today (August 22).

Leave a Reply

Your email address will not be published. Required fields are marked *